* Sabra Health Care REIT Inc SBRA.OQ SBRA.O is expected
to show a fall in quarterly revenue when it reports results on
February 22.
* The Irvine California-based company is expected to report
a
0.3% decrease in revenue to $151.638 million from $152.05
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Sabra Health Care
REIT
Inc is for earnings of 14 cents per share. For the same quarter
last year, the company reported earnings of 18 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 6
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Sabra
Health Care
REIT Inc is $16, about 15.4% above its last closing price
of $13.54.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 0.39 0.39 0.38 Missed -2.2
Jun. 30 2021 0.39 0.39 0.39 Met -1.2
Mar. 31 2021 0.40 0.40 0.40 Met -0.4
Dec. 31 2020 0.44 0.43 0.42 Missed -2.9
Sep. 0.42 0.42 0.48 Beat 14.1
30 2020
Jun. 30 2020 0.39 0.40 0.45 Beat 13.5
Mar. 31 2020 0.44 0.44 0.45 Beat 2.8
Dec. 31 2019 0.45 0.45 0.48 Beat 6
This summary was machine generated February 18 at 16:41 GMT.
All figures in US dollars unless otherwise stated